Literature DB >> 9833310

Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes.

E H Weil1, J L Ruiz-Cerdá, P H Eerdmans, R A Janknegt, P E Van Kerrebroeck.   

Abstract

The aim of this study was to determine the long-term clinical efficacy and complications of neuromodulation with a unilateral sacral foramen electrode in 36 patients with chronic voiding dysfunction. Following a positive effect of a percutaneous nerve evaluation test, patients underwent open surgery. A permanent electrode was implanted in 24 patients with urge incontinence, in 6 with urgency-frequency syndrome, and in 6 with nonobstructive urinary retention. After an average follow-up period of 37.8 months, 19 patients (52.8%) continue to benefit from the neuromodulation with a significant improvement of symptoms and urodynamic parameters. The median duration of the therapeutic effect for the total study population was longer than 60 months. No significant difference in the median duration of therapeutic effect with regard to sex, the type of voiding disorder, or the implant pulse generator was found. However, in patients with previous psychological disorders the median duration of therapeutic effect was only 12 months (P = 0.008). Complications were mild. In the group of patients in whom the therapeutic effect remains, 37 reoperations have had to be performed. We conclude that although reoperations were needed to overcome technical problems, patients can achieve lasting symptomatic improvement. Since technical changes in the equipment have reduced the number of complications, even better results can be expected in terms of the reoperation rate.

Entities:  

Mesh:

Year:  1998        PMID: 9833310     DOI: 10.1007/s003450050074

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  14 in total

Review 1.  Selection of ideal candidates for neuromodulation in refractory overactive bladder.

Authors:  Ravi Kacker; Anurag K Das
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

2.  Urinary retention during sacral nerve stimulation for faecal incontinence: report of a case.

Authors:  Hanne B Michelsen; Steen Buntzen; Klaus Krogh; Søren Laurberg
Journal:  Int J Colorectal Dis       Date:  2006-01-13       Impact factor: 2.571

3.  Sacral neuromodulation treating chronic pelvic pain: a meta-analysis and systematic review of the literature.

Authors:  Amr Mahran; Gina Baaklini; Daisy Hassani; Hassan A Abolella; Ahmed S Safwat; Mandy Neudecker; Adonis K Hijaz; Sangeeta T Mahajan; Steven W Siegel; Sherif A El-Nashar
Journal:  Int Urogynecol J       Date:  2019-03-14       Impact factor: 2.894

4.  Surgical options for drug-refractory overactive bladder patients.

Authors:  Jonathan S Starkman; Christopher P Smith; David R Staskin
Journal:  Rev Urol       Date:  2010

5.  A modified approach to patient's selection with improved clinical outcomes in sacral nerve modulation.

Authors:  Patrick Richard; Maude Carmel; Bechir Hage; Sophie Ramsay; Le Mai Tu
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

6.  Treatment of urinary voiding dysfunction syndromes with spinal cord stimulation.

Authors:  Alexander E Yakovlev; Beth E Resch
Journal:  Clin Med Res       Date:  2010-03

7.  Permanent sacral nerve stimulation for fecal incontinence.

Authors:  A J Malouf; C J Vaizey; R J Nicholls; M A Kamm
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

8.  Differences in sacral neuromodulation device infection rates based on preoperative antibiotic selection.

Authors:  Allen M Haraway; J Quentin Clemens; Chang He; Cynthia Stroup; Humphrey O Atiemo; Anne P Cameron
Journal:  Int Urogynecol J       Date:  2013-05-22       Impact factor: 2.894

Review 9.  Update on sacral neuromodulation: indications and outcomes.

Authors:  Magdy Hassouna; N Elmayergi; M Abdelhady
Journal:  Curr Urol Rep       Date:  2003-10       Impact factor: 2.862

10.  Predictive Factors in Sacral Neuromodulation: A Systematic Review.

Authors:  Ranjana Jairam; Jamie Drossaerts; Tom Marcelissen; Gommert van Koeveringe; Desiree Vrijens; Philip van Kerrebroeck
Journal:  Urol Int       Date:  2021-05-31       Impact factor: 1.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.